1. Home
  2. VSME vs ALZN Comparison

VSME vs ALZN Comparison

Compare VSME & ALZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VS Media Holdings Limited

VSME

VS Media Holdings Limited

HOLD

Current Price

$1.05

Market Cap

5.0M

Sector

N/A

ML Signal

HOLD

Logo Alzamend Neuro Inc.

ALZN

Alzamend Neuro Inc.

N/A

Current Price

$1.21

Market Cap

5.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
VSME
ALZN
Founded
2013
2016
Country
Singapore
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.0M
5.5M
IPO Year
2022
2021

Fundamental Metrics

Financial Performance
Metric
VSME
ALZN
Price
$1.05
$1.21
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 100.3K
31.3K
Earning Date
04-30-2026
12-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 76.77
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.07
$0.84
52 Week High
$5.38
$2.61

Technical Indicators

Market Signals
Indicator
VSME
ALZN
Relative Strength Index (RSI) 60.67 37.84
Support Level $1.05 $1.20
Resistance Level $1.16 $1.25
Average True Range (ATR) 0.10 0.10
MACD 0.02 0.00
Stochastic Oscillator 97.86 33.36

Price Performance

Historical Comparison
VSME
ALZN

About VSME VS Media Holdings Limited

VS Media Holdings Ltd manages a network of digital Creators who create and publish content to social media platforms such as YouTube, Facebook, Instagram, and TikTok. Its Creators include influencers, KOLs-Key Opinion Leaders, bloggers, and other content creators who cultivate fan bases on social media platforms. The company's business provides value to two business stakeholders: marketing services and social commerce. The firm generates almost all of its revenue from marketing services, which reflects the company's business of marketing services to clients and social media platforms. The social commerce segment reflects the company's business of social commerce with customers. Geographically, the firm generates revenue from the HK SAR and Taiwan.

About ALZN Alzamend Neuro Inc.

Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's disease. The Company has two therapeutic drug candidates, AL001 and ALZN002. Its pipeline consists of AL001, a patented ionic cocrystal technology delivering lithium through a therapeutic combination of lithium, proline and salicylate; and ALZN002, a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's disease.

Share on Social Networks: